Instil Bio Inc reports results for the quarter ended in December - Earnings Summary

Instil Bio

31/03/2023 12:35

* Instil Bio Inc  TIL.OQ  reported a quarterly adjusted loss
of 24
cents​​ per share for the quarter ended in December. The mean
expectation of four analysts for the quarter was for a loss
of 41 cents per share.
    * Reported revenue was zero​; analysts expected $500.00
thousand. 
    * Instil Bio Inc's reported EPS for the quarter was a loss
of 41
cents​.
    * The mean earnings estimate of analysts had risen by
about 2.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Instil Bio Inc shares had risen by 5.3% this quarter.
    * The company reported a quarterly loss of $53.84 million.
    * Wall Street's median 12-month price target for Instil Bio
Inc is
$5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 31 at 11:35 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.41          -0.24          Beat
 Sep. 30 2022      -0.44          -0.43          Beat
 Jun. 30 2022      -0.41          -0.46          Missed
 Mar. 31 2022      -0.38          -0.42          Missed